UNSPSC 51192020: Probenecid sodium

This classification denotes a uricosuric agent with the molecular formula C13H18NO4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FXB45Q4ZVK, chemically known as sodium 4-((dipropylamino)sulfonyl)benzoate, but more generally known as probenecid sodium, which bears US NIH Compound Identifier 32095. European Medicines Agency schedules probenecid sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10053MIG.

Most nations, for tariff purposes, schedule probenecid sodium under HS 29350090. SMILES: CCCN(CCC)S(=O)(=O)C1CCC(CC1)C(=O)[O-].[NA+].

UNSPSC 51192020 Probenecid sodium, a Commodity code, shows minimal relevant recent activity in state and local procurement. The three posted opportunities tagged under this pharmaceutical code bear no connection to probenecid sodium or any pharmaceutical procurement: Washington County, Oregon posted an RFP for a District Attorney's Office Dog (due August 14, 2026); the City of Tucson posted an RFP for athletic training services for fire and police departments (due June 9, 2026); and the City of Tampa posted an ITB for medical aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, and first aid kits (due April 9, 2025). None of these solicitations involve probenecid sodium or related pharmaceutical goods, indicating a significant mismatch between the code's nominal scope and actual state and local procurement needs tagged under it.

The geographic spread of the three unrelated opportunities spans Oregon, Arizona, and Florida, with no concentration suggesting pharmaceutical demand in any jurisdiction. The lack of authentic probenecid sodium solicitations suggests this code sees little to no active pursuit in state and local markets, making it a low-priority tracking target for business development focused on pharmaceutical or medical supply procurement at the municipal or county level.